Zobrazeno 1 - 10
of 124
pro vyhledávání: '"Salam Alkindi"'
Autor:
Salam Alkindi, Salma Al-Jadidi, Safa Al-Adawi, Refaat Abdullah Elsadek, Ali Al Madhani, Maryam Al-Nabhani, Anil V. Pathare
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-9 (2024)
Abstract Sickle cell disease (SCD) is a major public health burden worldwide with increasing morbidity and mortality. The study evaluates the risk factors associated with mortality in SCD patients, between the years 2006 and 2020 at three hospitals i
Externí odkaz:
https://doaj.org/article/60ee325b232941d6a225a1372d4a724b
Publikováno v:
Frontiers in Medicine, Vol 10 (2023)
BackgroundSickle cell disease is an inherited disorder characterized by the presence of sickle hemoglobin (HbS). The process of Hb molecule polymerization is a pivotal step in the sickling process. Voxelotor, a recently approved novel therapeutic age
Externí odkaz:
https://doaj.org/article/9322b2f79ae640a8a92be39d7c6d3d92
Autor:
Salam Alkindi, Anwaar R Al-Ghadani, Samah R Al-Zeheimi, Said Y Alkindi, Naglaa Fawaz, Samir K Ballas, Anil V Pathare
Publikováno v:
Journal of International Medical Research, Vol 49 (2021)
Objective To assess the clinical and laboratory predictors of venous thromboembolism (VTE) in patients with sickle cell anaemia (SCA) and its relationship to morbidity and mortality. Methods This retrospective case–control study analysed data from
Externí odkaz:
https://doaj.org/article/95ea4dfd75d2493b9f26a8775569912b
Publikováno v:
Frontiers in Medicine, Vol 8 (2021)
The treatment of sickle cell disease (SCD) is mainly supportive, except for a minority, who receive bone marrow transplantation (BMT). Serum ferritin (SF) is routinely available but is notoriously unreliable as a tool for iron-overload assessment sin
Externí odkaz:
https://doaj.org/article/e0b4395725b34744a70b9d0577141ebb
Publikováno v:
Mediterranean Journal of Hematology and Infectious Diseases, Vol 13, Iss 1 (2021)
Vaccines against acute respiratory syndrome Coronavirus 2(SARS-CoV2) are critical weapons to control the spread of the deadly Coronavirus 2019(COVId-19) virus worldwide. Although these vaccines are generally safe, their widespread use has produced re
Externí odkaz:
https://doaj.org/article/9652ed4bd21045f4b7f6702169d4ba0d
Autor:
Eltigani Hassan Ali, Salam Alkindi, Mohamed A. Osman, Wafa Hilali, Hind M. Mirgani, Gareeba Adam, Magdi M. Morsi, Izzeldin S. Hussein, Kebreab Ghebremeskel
Publikováno v:
Oman Medical Journal, Vol 36, Iss 3, Pp e270-e270 (2021)
Objectives: We sought to investigate the nutritional and hematological status of Sudanese women of childbearing age with sickle cell anemia (SCA). Anthropometry and hematology were used to assess nutritional status and health and disease conditions,
Externí odkaz:
https://doaj.org/article/3100ee15e5de48979f69ed23fde6d0ca
Autor:
Salam Alkindi, Shoaib Al Zadjali, Mohamed Al Rawahi, Hamoud Al Haddabi, Shahina Daar, Refaat Abdullah Elsadek, Bahaa Eldeen Diab Sherkawy, Anil Pathare
Publikováno v:
Mediterranean Journal of Hematology and Infectious Diseases, Vol 13, Iss 1 (2021)
Abstract Hemoglobin La Desirade (Hb La Desirade) is an unstable hemoglobin variant characterized by amino acid Alanine (Ala) replacing Valine (Val) at position 129 (H7) in the beta chain. Hb La Desirade exhibits a decreased oxygen affinity and normal
Externí odkaz:
https://doaj.org/article/7a3093bc59dd4176ad153ffc2497e438
Publikováno v:
Oman Medical Journal, Vol 35, Iss 6, Pp e197-e197 (2020)
Objectives: Patients with sickle cell anemia (SCA) are immunocompromised and at an increased risk of developing infections. Our aim was to establish the clinical, laboratory, and radiological manifestations of respiratory viral infections in SCA at S
Externí odkaz:
https://doaj.org/article/f3b38d30d18c456eb23cc3f48d22364d
Autor:
Salam Alkindi
Publikováno v:
Hematology, Transfusion and Cell Therapy, Vol 42, Iss , Pp 8- (2020)
Externí odkaz:
https://doaj.org/article/1ba82ae96a1a4706a46dc6abacbb7dfa
Autor:
Anil Pathare, Salam Alkindi, prof.
Publikováno v:
Mediterranean Journal of Hematology and Infectious Diseases, Vol 11, Iss 1 (2019)
Background: In Oman, the prevalence of hepatitis B (HBV) infection is 5.8% with 2.8–7.1% HBV carriers. Hepatitis C (HCV) prevalence amongst Omanis is 0.41%. A total of 2917 human immunodeficiency virus (HIV) infections were notified amongst Omanis
Externí odkaz:
https://doaj.org/article/65c94de774ca46388f49fbac244a1ec1